Literature DB >> 20141838

Structural and energetic mechanisms of cooperative autoinhibition and activation of Vav1.

Bingke Yu1, Ilídio R S Martins, Pilong Li, Gaya K Amarasinghe, Junko Umetani, Martin E Fernandez-Zapico, Daniel D Billadeau, Mischa Machius, Diana R Tomchick, Michael K Rosen.   

Abstract

Vav proteins are guanine nucleotide exchange factors (GEFs) for Rho family GTPases. They control processes including T cell activation, phagocytosis, and migration of normal and transformed cells. We report the structure and biophysical and cellular analyses of the five-domain autoinhibitory element of Vav1. The catalytic Dbl homology (DH) domain of Vav1 is controlled by two energetically coupled processes. The DH active site is directly, but weakly, inhibited by a helix from the adjacent Acidic domain. This core interaction is strengthened 10-fold by contacts of the calponin homology (CH) domain with the Acidic, pleckstrin homology, and DH domains. This construction enables efficient, stepwise relief of autoinhibition: initial phosphorylation events disrupt the modulatory CH contacts, facilitating phosphorylation of the inhibitory helix and consequent GEF activation. Our findings illustrate how the opposing requirements of strong suppression of activity and rapid kinetics of activation can be achieved in multidomain systems. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20141838      PMCID: PMC2825156          DOI: 10.1016/j.cell.2009.12.033

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  41 in total

1.  Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential.

Authors:  S Katzav; J L Cleveland; H E Heslop; D Pulido
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

2.  Vav family GEFs link activated Ephs to endocytosis and axon guidance.

Authors:  Christopher W Cowan; Yu Raymond Shao; Mustafa Sahin; Steven M Shamah; Michael Z Lin; Paul L Greer; Sizhen Gao; Eric C Griffith; Joan S Brugge; Michael E Greenberg
Journal:  Neuron       Date:  2005-04-21       Impact factor: 17.173

3.  Structural analysis of autoinhibition in the Ras activator Son of sevenless.

Authors:  Holger Sondermann; Stephen M Soisson; Sean Boykevisch; Shao-Song Yang; Dafna Bar-Sagi; John Kuriyan
Journal:  Cell       Date:  2004-10-29       Impact factor: 41.582

4.  Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.

Authors:  I Moarefi; M LaFevre-Bernt; F Sicheri; M Huse; C H Lee; J Kuriyan; W T Miller
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

5.  Acidic region tyrosines provide access points for allosteric activation of the autoinhibited Vav1 Dbl homology domain.

Authors:  Gaya K Amarasinghe; Michael K Rosen
Journal:  Biochemistry       Date:  2005-11-22       Impact factor: 3.162

6.  Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.

Authors:  Zhongyun Dong; Yin Liu; Shan Lu; Amy Wang; Kiwon Lee; Lu-Hai Wang; Monica Revelo; Shan Lu
Journal:  Mol Endocrinol       Date:  2006-06-08

7.  Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav.

Authors:  J Han; K Luby-Phelps; B Das; X Shu; Y Xia; R D Mosteller; U M Krishna; J R Falck; M A White; D Broek
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

8.  Involvement of NH(2)-terminal sequences in the negative regulation of Vav signaling and transforming activity.

Authors:  K Abe; I P Whitehead; J P O'Bryan; C J Der
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

9.  Requirements for Vav guanine nucleotide exchange factors and Rho GTPases in FcgammaR- and complement-mediated phagocytosis.

Authors:  Amy B Hall; M Angelica Martinez Gakidis; Michael Glogauer; Julie L Wilsbacher; Sizhen Gao; Wojciech Swat; Joan S Brugge
Journal:  Immunity       Date:  2006-03       Impact factor: 31.745

10.  Internal dynamics control activation and activity of the autoinhibited Vav DH domain.

Authors:  Pilong Li; Ilídio R S Martins; Gaya K Amarasinghe; Michael K Rosen
Journal:  Nat Struct Mol Biol       Date:  2008-05-18       Impact factor: 15.369

View more
  80 in total

1.  Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.

Authors:  Galit Lazer; Liron Pe'er; Marganit Farago; Kazuya Machida; Bruce J Mayer; Shulamit Katzav
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Vav1 oncogenic mutation inhibits T cell receptor-induced calcium mobilization through inhibition of phospholipase Cγ1 activation.

Authors:  Mira Knyazhitsky; Etay Moas; Ekaterina Shaginov; Anna Luria; Alex Braiman
Journal:  J Biol Chem       Date:  2012-04-03       Impact factor: 5.157

3.  Rho guanosine nucleotide exchange factors are not such bad guys after all in cancera.

Authors:  Javier Robles-Valero; L Francisco Lorenzo-Martín; Isabel Fernández-Pisonero; Xosé R Bustelo
Journal:  Small GTPases       Date:  2018-01-24

4.  Structural basis for membrane recruitment and allosteric activation of cytohesin family Arf GTPase exchange factors.

Authors:  Andrew W Malaby; Bert van den Berg; David G Lambright
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

5.  Insights into the molecular activation mechanism of the RhoA-specific guanine nucleotide exchange factor, PDZRhoGEF.

Authors:  Jakub A Bielnicki; Alexander V Shkumatov; Urszula Derewenda; Avril V Somlyo; Dmitri I Svergun; Zygmunt S Derewenda
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

6.  Mechanistic insights into specificity, activity, and regulatory elements of the regulator of G-protein signaling (RGS)-containing Rho-specific guanine nucleotide exchange factors (GEFs) p115, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG).

Authors:  Mamta Jaiswal; Lothar Gremer; Radovan Dvorsky; Lars Christian Haeusler; Ion C Cirstea; Katharina Uhlenbrock; Mohammad Reza Ahmadian
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

7.  Genetic alterations affecting GTPases and T-cell receptor signaling in peripheral T-cell lymphomas.

Authors:  Rebecca L Boddicker; Gina L Razidlo; Andrew L Feldman
Journal:  Small GTPases       Date:  2017-01-06

8.  Upon Wnt stimulation, Rac1 activation requires Rac1 and Vav2 binding to p120-catenin.

Authors:  Gabriela Valls; Montserrat Codina; Rachel K Miller; Beatriz Del Valle-Pérez; Meritxell Vinyoles; Carme Caelles; Pierre D McCrea; Antonio García de Herreros; Mireia Duñach
Journal:  J Cell Sci       Date:  2012-09-03       Impact factor: 5.285

Review 9.  Advances in targeted therapy for malignant lymphoma.

Authors:  Li Wang; Wei Qin; Yu-Jia Huo; Xiao Li; Qing Shi; John E J Rasko; Anne Janin; Wei-Li Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-03-06

10.  The minimal autoinhibited unit of the guanine nucleotide exchange factor intersectin.

Authors:  K Farid Ahmad; Wendell A Lim
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.